InvestorsHub Logo
Followers 37
Posts 1127
Boards Moderated 0
Alias Born 08/23/2018

Re: invest2992 post# 300770

Tuesday, 09/22/2020 8:02:53 PM

Tuesday, September 22, 2020 8:02:53 PM

Post# of 424190
I know he’s CEO...but remember, he joined as CEO of a 500m company. Basically an average Silicon Valley startup, pre ipo. I agree a Fortune 500 CEO is better spoken, more aggressive making deals, etc. But those guys also make 20-200m a year. That was 5-50% of our market cap.

Amarin was a fighter. They believed they would win the court case and then easily get bought for 35+ (or some high number) or build out to selling 10b a year of vascepa. But none of them had ever done that before, been through such litigious battles, or grown a company from small to an 8b market cap. Honestly, if amarin did evolve into a 50b company, I’m sure JT would have eventually been replaced. But in the business scheme of things, everything happened so fast. They dropped hints here and there about bringing in outside counsel for BO or EU partnerships, but never seemed to seal any deals.

In the end of the day, we all won and made the right call. The drug works, it can be a 10b+ market, and the MOA. But the unknowns are where we got hurt. We were all exorbitant and had bias. Lawyers who said our chances were 50/50 for the first trial we all dismissed and said they were spreading FUD. Maybe they were, but they were also right this wasn’t a shoe in. Hikma and teddy are constantly fighting legal battles like this. Company is prepped, team is experienced, everything is streamlined. Sucks the good guys lost. Obviously the justice system can be duped, and we were on the losing side
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News